[Therapy of pulmonary mycoses].
Schaberg
T
T
Abteilung Pneumologie I (Infektiologie und Immunologie), Lungenklinik Heckeshorn, Krankenhaus Zehlendorf, Berlin.
Lode
H
H
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000188:drug therapy; D001759:Blastomycosis / Q000188:drug therapy; D003047:Coccidioidomycosis / Q000188:drug therapy; D003453:Cryptococcosis / Q000188:drug therapy; D015725:Fluconazole / Q000627:therapeutic use; D005437:Flucytosine / Q000627:therapeutic use; D006660:Histoplasmosis / Q000188:drug therapy; D006801:Humans; D017964:Itraconazole; D007654:Ketoconazole / Q000031:analogs & derivatives / Q000627:therapeutic use; D008172:Lung Diseases, Fungal / Q000188:drug therapy*
D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B; D015725:Fluconazole; D005437:Flucytosine; D007654:Ketoconazole
Therapie pulmonaler Mykosen.